Senna (Cassia angustifolia), commonly known as Indian senna, is a botanical plant belonging to the Fabaceae family. Its leaves and pods are important sources of naturally occurring compounds known as sennosides. Senna-derived materials are used in regulated botanical and pharmaceutical applications, with suitability depending on the material's identity, composition, quality, and applicable regulations.
Mediocon Inc. provides product information to help businesses evaluate Senna as a botanical ingredient. Buyers should confirm whether the available material is senna leaf, senna pod, dried plant material, powder, or a concentrated extract before selecting it for a particular application.
Senna contains naturally occurring anthraquinone glycosides, including sennosides. The concentration and profile of these constituents may vary with plant part, source, harvesting, processing, and extraction method.
Senna leaf, senna pod, whole-plant powder, and senna extract are distinct materials and should not be treated as interchangeable. An extract may have a defined sennoside specification, but the assay percentage and analytical method must be confirmed from the current product specification and certificate of analysis.
Colour, odour, moisture, particle size, solubility, extract ratio, and other physical or chemical characteristics depend on the product grade. Only verified values should be published as technical specifications.
Depending on product grade, regulatory status, and applicable quality requirements, Senna-derived materials may be evaluated for:
Senna is associated with stimulant laxative applications. Because it has pharmacological effects and specific safety considerations, its use must be appropriate to the intended product, dosage form, jurisdiction, and applicable regulatory requirements. It should not be promoted as a general-purpose food or wellness ingredient without confirming legal and safety suitability.
For commercial sourcing, buyers should confirm botanical identity, plant part, product form, extraction method, sennoside assay where applicable, and the validated analytical method used. Relevant quality checks may include moisture, microbiological quality, heavy metals, pesticide residues, foreign matter, and residual solvents for extracted products.
For pharmaceutical applications, additional requirements may apply, including pharmacopeial compliance, manufacturing controls, traceability, and documentation for the intended market. Do not claim a pharmacopeial grade, standardized sennoside percentage, or certification unless it is supported by current product documentation.
Follow the storage instructions on the product label and technical data sheet. Keep the material in appropriate, well-sealed packaging and protect it from moisture, contamination, direct sunlight, and unsuitable temperatures. Observe all handling precautions and the stated shelf life.
Mediocon Inc. provides product information for businesses evaluating botanical ingredients and related raw materials. Buyers interested in Senna should confirm the exact botanical identity, plant part, available form, grade, sennoside specification, documentation, and regulatory suitability before purchasing.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Senna (Cassia angustifolia) Manufacturer in India and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Senna (Cassia angustifolia) Manufacturer in India is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance